Skip to main content
SMFM 2026 Pregnancy Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared outside of the session
Faculty have requested this content not be shared outside of the session
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Recording available 2/16-5/2
Recording available 2/16-5/2
AIUM Credit
AIUM Credit
Foundation Awardee
Foundation Awardee
Poster Icons
Abstract Award
Abstract Award
Foundation Awardee
Foundation Awardee

Industry-Supported Learning

Managing The Alloimmunized Pregnancy: Breakthroughs with cfDNA

Monday, February 9, 2026
12:00 PM - 1:00 PM  
Location: Academy 407 - 409

Sponsored By 

    Industry Session Presenter(s)

  • Jennifer Hoskovec

    Vice President of Medical Affairs
    BillionToOne

  • Haywood Brown, MD (me)

    Emeritus Professor and Chair Obstetrics and Gynecology
    Duke University
    Tampa, Florida, United States

  • Kenneth Moise, Jr., MD (he/him/his)

    Co-Director, Comprehensive Fetal Care Center; Prof, Women’s Health
    Department of Women’s Health, Dell Medical School at the University of Texas at Austin
    Austin, Texas, United States

This independent presentation is not part of the official program as planned by the SMFM Pregnancy Meeting™ Program Committee. The content of this session is not endorsed by or recommended by SMFM.

Review this year’s key advancements in cfDNA-based fetal antigen testing for alloimmunized pregnancies. This session covers new clinical advancements and emerging evidence showing how cfDNA can guide more personalized management.